No abstract

Case History A 68 years old male patient was admitted with febrile illness in February 2010. His routine work up was inconclusive for diagnosis of common infectious cause of acute febrile illness. He responded to antibiotic treatment. His HIV ELISA (4 th generation of ELISA for HIV 1 and 2; result 0.0 by Enzyme linked fluorescent assay [ELFA]) and Western blot test were negative (27/2/2010). His P24 Antigen assay with ELFA was positive.

No abstract

Fixed-dose formulations of NVP-based combination therapy are safe and produced durable clinical and immunologic benefit.

Clinical and immunologic benefits are comparable for patients receiving efavirenz-based antiretroviral therapy with or without rifampicin.